Galectin Therapeutics (GALT) Shares Outstanding (Entity) (2010 - 2026)
Galectin Therapeutics (GALT) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 254.16 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 147.69 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 200.18 Mn |
| 10 | Galectin Therapeutics | 227.21 Mn | 227.21 Mn | - | 65.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 65.86 Mn |
| Dec 31, 2025 | 65.20 Mn |
| Sep 30, 2025 | 64.47 Mn |
| Jun 30, 2025 | 64.06 Mn |
| Mar 31, 2025 | 63.29 Mn |
| Dec 31, 2024 | 63.16 Mn |
| Sep 30, 2024 | 62.31 Mn |
| Jun 30, 2024 | 62.28 Mn |
| Mar 31, 2024 | 62.15 Mn |
| Dec 31, 2023 | 61.85 Mn |
| Sep 30, 2023 | 61.85 Mn |
| Jun 30, 2023 | 59.58 Mn |
| Mar 31, 2023 | 59.58 Mn |
| Dec 31, 2022 | 59.43 Mn |
| Sep 30, 2022 | 59.43 Mn |
| Jun 30, 2022 | 59.40 Mn |
| Mar 31, 2022 | 59.39 Mn |
| Dec 31, 2021 | 59.34 Mn |
| Sep 30, 2021 | 59.34 Mn |
| Jun 30, 2021 | 59.28 Mn |